AzTrials
AzTrials

Diet, HealthyGutEnergyNCT06932666

Why Calories Are Not the Same - a Gut Explanation?

A study testing Diet A group and Diet B group in people with Diet, Healthy and Breath Analysis, run by University of Copenhagen at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to understand how the gut microbiome influences how much dietary energy humans excrete via feces. This study is based on the hypothesis that levels of methane in exhaled breath represent two different gut microbiome community structures, and therefore influence fecal energy excretion… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Diet, Healthy, Breath Analysis
What is being tested?
Diet A group and Diet B group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteDenmark
Study dates
15 May 2025to 13 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18-65 years old
  • BMI:18.5-29.9 kg/m2
  • Self-reported regular defecations defined as at least every second day
  • Willing to collect urine and stool samples at home and able to temporarily store them in their own freezer in a provided container
  • Willing to exclusively eat the food provided
  • Owning a smartphone (iOS 11.0 and onwards, or Android 5.0 and onwards) with access to the internet
  • Speak and understand Danish or English

Who cannot join

  • Current pregnancy or lactation
  • Following a specific dietary program or diet (e.g., vegetarian, vegan, gluten-free) or unable to consume the food provided
  • Diagnosis of small intestinal bacterial overgrowth (SIBO), inflammatory bowel diseases (IBD), gastrointestinal obstruction, or ischemic colitis
  • Diagnosed chronic constipation
  • Regular use of diarrhea inhibitors or laxatives
  • Any chronic disease that can affect the outcomes of the study
Show all 11Show fewer
  • Use of medications potentially altering gastric pH (proton pump inhibitors, histamine receptor antagonists, antacids)
  • Use of medications potentially altering the gastro-intestinal motility (prokinetics, antiemetic agents, anticholinergic agents, narcotic analgesics, nonsteroidal anti-inflammatory drugs, peroral glucocorticoids, and GLP-1 related medications such as semaglutide and liraglutide)
  • Use of antibiotics, or any medication that can affect any outcomes of the study, within the previous three months
  • Concurrent participation in another trial
  • Any condition that makes the project responsible and/or the clinical responsible doubt the feasibility of the volunteer's participation

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • University of Copenhagen, Department of Nutrition, Exercise and Sports

    Frederiksberg, Capital Region, 1958

Other trials in Denmark

About this study

Official title: Why Calories Are Not the Same - a Gut Explanation

The aim of this study is to understand how the gut microbiome influences how much dietary energy humans excrete via feces. This study is based on the hypothesis that levels of methane in exhaled breath represent two different gut microbiome community structures, and therefore influence fecal energy excretion differently. Moreover, this study is assessed in the context of two different diets, both isocaloric and equal in macronutrient composition, but differing in contents of fiber, resistant starch, and large particles; which are hypothesized to impact the gut microbiome differently.

Read the detailed description

The trial is a cross-over trial including two controlled isocaloric dietary interventions of three days duration. The two diets are isocaloric but with different contents of fiber, resistant starch, and food particle sizes. Each intervention is separated by a wash-out period of at least 10 days where participants adhere to their habitual diet. The trial includes a total of five visits (one screening visit and four regular visits).

Before the trial, participants undergo a screening period of 4 days. During the 4-day screening period, participants measure the levels of methane in their exhaled breath. Based on median breath methane levels, participants are allocated to one of the two arms: (HMP: high methane producers; LMP: low methane producers). Enrollment in the intervention trial will be conducted so there are similar numbers of participants in both arms.

At the beginning and at the end of each 3-day intervention period, participants consume a blue muffin, containing a royal blue dye that changes the stool color. The appearance of the color in stool following the first muffin will mark the beginning of the stool collection period, which will continue until the stool color change is no longer noticeable following consumption of the second muffin. Therefore, the duration of the stool collection period, which is estimated to be on average 3 days, will ultimately depend on the participants' passage time of food (i.e., intestinal transit time).

During the screening period, participants are asked to:

  • measure their methane and hydrogen levels in exhaled breath using a portable device
  • report defecation patterns (including stool frequency and Bristol Stool Scale)

Before each intervention period, participants are asked to:

  • collect a fecal and urine sample
  • register three days of habitual diet

At the visits before each intervention period, the following samples are collected:

  • a blood sample
  • methane and hydrogen measurements in exhaled breath
  • anthropometrics
  • data on physical activity

During the intervention periods, participants are asked to:

  • exclusively eat all the foods provided
  • collect all their stool samples, as specified above
  • collect three morning urine samples (one daily for the following three days)
  • measure their methane and hydrogen levels in their exhaled breath using a portable device
  • report their defecation patterns and gastrointestinal symptoms
Being tested
Diet A group, Diet B group
Keywords
Fecal energy, Metabolizable energy, Breath methane, Gut microbiome, Metabolomics, Dietary fiber, Resistant starch, Food particle size

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diet A groupOther

    Diet high in fiber (> 40g/10MJ), high in resistant starch (> 10g/10MJ), and containing large food particles. Diet is provided for 3 full days, consists of three meals per day (breakfast, lunch, and dinner) and in-between meals, and covers 100% of the participants' energy requirements.

  • Diet B groupOther

    Diet low in fiber (< 10g/10MJ), low in resistant starch (< 3g/10MJ) and containing small food particles. Diet is provided for 3 full days, consists of three meals per day (breakfast, lunch, and dinner) and in-between meals, and covers 100% of the participants' energy requirements.

Study groups in NCT06932666
Study groupRoleWhat they receive
High-methane producersExperimentalIndividuals exhaling high levels of methane (median exhaled methane >= 5 ppm), as measured 3-times daily during the screening period.
Receives: Other: Diet A group; Other: Diet B group
Low-methane producersExperimentalIndividuals exhaling low levels of methane (median exhaled methane < 5 ppm), as measured 3-times daily during the screening period.
Receives: Other: Diet A group; Other: Diet B group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total fecal energy excretion (between high- and low-methane producers)

    Differences in total fecal energy excretion, determined as total kilocalories excreted via feces, between low and high methane producers following intake of the two controlled, isocaloric diets.

    Measured: During each stool collection period (following each 3-day intervention period)

Secondary outcomes (14)
  1. Total fecal energy excretion (between diet A and diet B)

    Differences in total fecal energy excretion, determined as total kilocalories excreted via feces, between the two isocaloric diets (that differ in fiber, resistant starch, and particle size).

    Measured: During each stool collection period (following each 3-day intervention period)

  2. Fecal energy density

    Differences in fecal energy density, determined as fecal energy (kcal) relative to fecal weight, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  3. Total fecal weight excreted

    Differences in total fecal weight excreted, determined as dry weight (grams), between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  4. Breath hydrogen and methane levels

    Differences in breath methane and hydrogen concentration in exhaled breath, measured in parts per million (PPM), between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  5. Whole-gut transit time

    Differences in whole-gut transit time, determined by the passage time of muffins with blue dye, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  6. Stool consistency

    Differences in stool consistency, determined by Bristol Stool Scale, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  7. Stool frequency

    Differences in stool frequency, determined by defecation records registered by the participants, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  8. Stool moisture

    Differences in stool moisture, determined as fecal water content relative to fecal weight, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  9. Fecal pH

    Differences in fecal pH between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  10. Fecal microbial load

    Differences in fecal microbial load, determined as total microbial DNA reads in feces, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  11. Fecal host DNA concentration

    Differences in fecal host DNA concentration, determined as total human DNA reads in feces, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  12. Fecal short-chain fatty acids

    Differences in fecal short-chain fatty acid concentrations between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  13. Gut microbiome composition (16S)

    Differences in gut microbiome composition, determined by 16S amplicon sequencing of fecal DNA, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

  14. Gut microbiome composition and functions (shotgun sequencing)

    Differences in gut microbiome taxonomic composition and functions, determined by shotgun sequencing of fecal DNA, between high- and low-methane producers.

    Measured: During each 3-day intervention period and its following stool collection period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2025
  2. Study start15 May 2025
  3. Primary completion13 May 2026
  4. Study completion13 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Crossover
Model description
Overall, there are two parallel arms - high- (HMP) and low- (LMP) methane producers, to which the participants are allocated in a ratio 1:1 after a 4-day screening period, where individual levels of methane in exhaled breath are measured multiple times. In both arms, participants undergo two 3-days dietary interventions in a crossover design and separated by a +10-day washout period. Participants are randomized to receiving diet A first or diet B first. These two diets are isocaloric and equal in macronutrient composition, but differ on dietary fiber, resistant starch and food particle size.
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06932666
Sponsor's protocol ID
M408
Acronym
GutEnergy
Status last verified
Jun 2026
First submitted
10 Apr 2025
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Diet A group and Diet B group in people with Diet, Healthy and Breath Analysis, run by University of Copenhagen at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total fecal energy excretion (between high- and low-methane producers) (time frame: During each stool collection period (following each 3-day intervention period)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in